id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-0289-0001,FDA,FDA-2022-N-0289,"Medical Devices; Cardiovascular
Devices; Classification of the Reverse
Central Venous Recanalization System",Rule,Final Rule,2022-05-06T04:00:00Z,2022,5,2022-05-06T04:00:00Z,,2022-05-06T15:54:47Z,2022-09745,0,0,0900006485056077